nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—SCN5A—dilated cardiomyopathy	0.757	1	CbGaD
Ropivacaine—SCN5A—purkinje fiber—dilated cardiomyopathy	0.041	0.45	CbGeAlD
Ropivacaine—SCN5A—endocardium—dilated cardiomyopathy	0.0211	0.232	CbGeAlD
Ropivacaine—SCN5A—sinoatrial node—dilated cardiomyopathy	0.02	0.22	CbGeAlD
Ropivacaine—SCN8A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00528	0.0687	CbGpPWpGaD
Ropivacaine—SCN9A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00427	0.0556	CbGpPWpGaD
Ropivacaine—SCN3A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00409	0.0532	CbGpPWpGaD
Ropivacaine—SCN4A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00393	0.0511	CbGpPWpGaD
Ropivacaine—SCN2A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00393	0.0511	CbGpPWpGaD
Ropivacaine—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00379	0.0493	CbGpPWpGaD
Ropivacaine—SCN1A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00379	0.0493	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00203	0.0264	CbGpPWpGaD
Ropivacaine—Mepivacaine—SCN5A—dilated cardiomyopathy	0.00188	0.254	CrCbGaD
Ropivacaine—Ranolazine—SCN5A—dilated cardiomyopathy	0.00188	0.254	CrCbGaD
Ropivacaine—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00178	0.0195	CbGeAlD
Ropivacaine—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00172	0.0253	CcSEcCtD
Ropivacaine—SCN5A—myocardium—dilated cardiomyopathy	0.00167	0.0184	CbGeAlD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	0.00164	0.0214	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00164	0.0213	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00157	0.0204	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00151	0.0196	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00151	0.0196	CbGpPWpGaD
Ropivacaine—SCN4A—heart—dilated cardiomyopathy	0.0015	0.0165	CbGeAlD
Ropivacaine—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0015	0.0221	CcSEcCtD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	0.00146	0.0191	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00145	0.0189	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00145	0.0189	CbGpPWpGaD
Ropivacaine—Tocainide—SCN5A—dilated cardiomyopathy	0.0014	0.189	CrCbGaD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	0.00125	0.0162	CbGpPWpGaD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	0.00125	0.0162	CbGpPWpGaD
Ropivacaine—SCN3A—heart—dilated cardiomyopathy	0.00117	0.0129	CbGeAlD
Ropivacaine—SCN5A—heart—dilated cardiomyopathy	0.00117	0.0128	CbGeAlD
Ropivacaine—Injection site pain—Furosemide—dilated cardiomyopathy	0.00116	0.0172	CcSEcCtD
Ropivacaine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00114	0.0168	CcSEcCtD
Ropivacaine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00111	0.0164	CcSEcCtD
Ropivacaine—Lidocaine—SCN5A—dilated cardiomyopathy	0.00108	0.146	CrCbGaD
Ropivacaine—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00104	0.0153	CcSEcCtD
Ropivacaine—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000998	0.011	CbGeAlD
Ropivacaine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000978	0.0144	CcSEcCtD
Ropivacaine—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.000932	0.0137	CcSEcCtD
Ropivacaine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000932	0.0137	CcSEcCtD
Ropivacaine—Oliguria—Lisinopril—dilated cardiomyopathy	0.000774	0.0114	CcSEcCtD
Ropivacaine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000772	0.0114	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000766	0.00997	CbGpPWpGaD
Ropivacaine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000759	0.0112	CcSEcCtD
Ropivacaine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000735	0.0108	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000722	0.00939	CbGpPWpGaD
Ropivacaine—Purpura—Furosemide—dilated cardiomyopathy	0.000716	0.0106	CcSEcCtD
Ropivacaine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000713	0.0105	CcSEcCtD
Ropivacaine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000713	0.0105	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000713	0.0105	CcSEcCtD
Ropivacaine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000709	0.0105	CcSEcCtD
Ropivacaine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000701	0.0103	CcSEcCtD
Ropivacaine—Malaise—Spironolactone—dilated cardiomyopathy	0.000689	0.0102	CcSEcCtD
Ropivacaine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00067	0.00988	CcSEcCtD
Ropivacaine—Urinary retention—Furosemide—dilated cardiomyopathy	0.000656	0.00968	CcSEcCtD
Ropivacaine—Discomfort—Spironolactone—dilated cardiomyopathy	0.000643	0.00948	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00063	0.0093	CcSEcCtD
Ropivacaine—Confusional state—Spironolactone—dilated cardiomyopathy	0.000629	0.00927	CcSEcCtD
Ropivacaine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000628	0.00926	CcSEcCtD
Ropivacaine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000624	0.00919	CcSEcCtD
Ropivacaine—Lidocaine—SLC22A5—dilated cardiomyopathy	0.000622	0.084	CrCbGaD
Ropivacaine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000622	0.00916	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00062	0.00806	CbGpPWpGaD
Ropivacaine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00061	0.009	CcSEcCtD
Ropivacaine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000601	0.00886	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000593	0.00771	CbGpPWpGaD
Ropivacaine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000593	0.00874	CcSEcCtD
Ropivacaine—CYP2B6—heart—dilated cardiomyopathy	0.000589	0.00647	CbGeAlD
Ropivacaine—SCN9A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000584	0.00759	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00057	0.00741	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00057	0.00741	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000558	0.00726	CbGpPWpGaD
Ropivacaine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000554	0.00817	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000549	0.00714	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000549	0.00714	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000547	0.00711	CbGpPWpGaD
Ropivacaine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000546	0.00806	CcSEcCtD
Ropivacaine—Lidocaine—EGFR—dilated cardiomyopathy	0.000541	0.0731	CrCbGaD
Ropivacaine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000538	0.00793	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000536	0.00698	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000536	0.00698	CbGpPWpGaD
Ropivacaine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000535	0.00789	CcSEcCtD
Ropivacaine—SCN8A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000535	0.00696	CbGpPWpGaD
Ropivacaine—Drowsiness—Furosemide—dilated cardiomyopathy	0.000532	0.00784	CcSEcCtD
Ropivacaine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000531	0.00782	CcSEcCtD
Ropivacaine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000518	0.00764	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000517	0.00673	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000517	0.00673	CbGpPWpGaD
Ropivacaine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000514	0.00758	CcSEcCtD
Ropivacaine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000495	0.0073	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000494	0.00642	CbGpPWpGaD
Ropivacaine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000493	0.00727	CcSEcCtD
Ropivacaine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000492	0.00726	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000473	0.00697	CcSEcCtD
Ropivacaine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000472	0.00695	CcSEcCtD
Ropivacaine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000468	0.0069	CcSEcCtD
Ropivacaine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000468	0.0069	CcSEcCtD
Ropivacaine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000466	0.00688	CcSEcCtD
Ropivacaine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000459	0.00677	CcSEcCtD
Ropivacaine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000445	0.00656	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000442	0.00575	CbGpPWpGaD
Ropivacaine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000441	0.0065	CcSEcCtD
Ropivacaine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00044	0.00649	CcSEcCtD
Ropivacaine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000436	0.00643	CcSEcCtD
Ropivacaine—SCN9A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000433	0.00563	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00043	0.00559	CbGpPWpGaD
Ropivacaine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000427	0.00629	CcSEcCtD
Ropivacaine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000427	0.00629	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000423	0.0055	CbGpPWpGaD
Ropivacaine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000419	0.00617	CcSEcCtD
Ropivacaine—Erythema—Furosemide—dilated cardiomyopathy	0.000416	0.00613	CcSEcCtD
Ropivacaine—SCN3A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000414	0.00538	CbGpPWpGaD
Ropivacaine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000412	0.00608	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000407	0.00529	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000407	0.00529	CbGpPWpGaD
Ropivacaine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000404	0.00595	CcSEcCtD
Ropivacaine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0004	0.00589	CcSEcCtD
Ropivacaine—Depression—Lisinopril—dilated cardiomyopathy	0.000398	0.00587	CcSEcCtD
Ropivacaine—SCN2A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000398	0.00517	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000398	0.00517	CbGpPWpGaD
Ropivacaine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000396	0.00585	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000393	0.0058	CcSEcCtD
Ropivacaine—Rash—Spironolactone—dilated cardiomyopathy	0.000393	0.0058	CcSEcCtD
Ropivacaine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000393	0.00579	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000392	0.0051	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000392	0.0051	CbGpPWpGaD
Ropivacaine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000392	0.00578	CcSEcCtD
Ropivacaine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000391	0.00577	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000391	0.00577	CcSEcCtD
Ropivacaine—Headache—Spironolactone—dilated cardiomyopathy	0.000391	0.00576	CcSEcCtD
Ropivacaine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000389	0.00574	CcSEcCtD
Ropivacaine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000388	0.00572	CcSEcCtD
Ropivacaine—Anaemia—Furosemide—dilated cardiomyopathy	0.000384	0.00566	CcSEcCtD
Ropivacaine—SCN1A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000383	0.00499	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000383	0.00499	CbGpPWpGaD
Ropivacaine—Agitation—Furosemide—dilated cardiomyopathy	0.000382	0.00563	CcSEcCtD
Ropivacaine—Haematuria—Lisinopril—dilated cardiomyopathy	0.000381	0.00561	CcSEcCtD
Ropivacaine—Vertigo—Furosemide—dilated cardiomyopathy	0.000373	0.00551	CcSEcCtD
Ropivacaine—Nausea—Spironolactone—dilated cardiomyopathy	0.00037	0.00546	CcSEcCtD
Ropivacaine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000365	0.00538	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000364	0.00473	CbGpPWpGaD
Ropivacaine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000359	0.0053	CcSEcCtD
Ropivacaine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000356	0.00526	CcSEcCtD
Ropivacaine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000354	0.00522	CcSEcCtD
Ropivacaine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000353	0.0052	CcSEcCtD
Ropivacaine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000351	0.00518	CcSEcCtD
Ropivacaine—SCN9A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000348	0.00452	CbGpPWpGaD
Ropivacaine—Confusional state—Furosemide—dilated cardiomyopathy	0.000342	0.00504	CcSEcCtD
Ropivacaine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000339	0.005	CcSEcCtD
Ropivacaine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000334	0.00493	CcSEcCtD
Ropivacaine—Shock—Furosemide—dilated cardiomyopathy	0.000334	0.00492	CcSEcCtD
Ropivacaine—SCN3A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000333	0.00433	CbGpPWpGaD
Ropivacaine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000332	0.0049	CcSEcCtD
Ropivacaine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000329	0.00486	CcSEcCtD
Ropivacaine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000328	0.00484	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000323	0.0042	CbGpPWpGaD
Ropivacaine—Chills—Lisinopril—dilated cardiomyopathy	0.000321	0.00474	CcSEcCtD
Ropivacaine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00032	0.00472	CcSEcCtD
Ropivacaine—SCN4A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00032	0.00416	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00032	0.00416	CbGpPWpGaD
Ropivacaine—Hypotension—Furosemide—dilated cardiomyopathy	0.000317	0.00467	CcSEcCtD
Ropivacaine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000314	0.00463	CcSEcCtD
Ropivacaine—Erythema—Lisinopril—dilated cardiomyopathy	0.000312	0.0046	CcSEcCtD
Ropivacaine—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000308	0.00401	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000308	0.00401	CbGpPWpGaD
Ropivacaine—Tension—Lisinopril—dilated cardiomyopathy	0.000306	0.00451	CcSEcCtD
Ropivacaine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000305	0.00449	CcSEcCtD
Ropivacaine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000303	0.00447	CcSEcCtD
Ropivacaine—Back pain—Lisinopril—dilated cardiomyopathy	0.000302	0.00445	CcSEcCtD
Ropivacaine—Somnolence—Furosemide—dilated cardiomyopathy	0.000302	0.00445	CcSEcCtD
Ropivacaine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.0003	0.00442	CcSEcCtD
Ropivacaine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000294	0.00433	CcSEcCtD
Ropivacaine—Tremor—Lisinopril—dilated cardiomyopathy	0.000292	0.00431	CcSEcCtD
Ropivacaine—Constipation—Furosemide—dilated cardiomyopathy	0.00029	0.00428	CcSEcCtD
Ropivacaine—Pain—Furosemide—dilated cardiomyopathy	0.00029	0.00428	CcSEcCtD
Ropivacaine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000289	0.00427	CcSEcCtD
Ropivacaine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000288	0.00425	CcSEcCtD
Ropivacaine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000285	0.0042	CcSEcCtD
Ropivacaine—Malaise—Lisinopril—dilated cardiomyopathy	0.000281	0.00415	CcSEcCtD
Ropivacaine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00028	0.00413	CcSEcCtD
Ropivacaine—Syncope—Lisinopril—dilated cardiomyopathy	0.00028	0.00412	CcSEcCtD
Ropivacaine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00028	0.00412	CcSEcCtD
Ropivacaine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000279	0.00363	CbGpPWpGaD
Ropivacaine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000277	0.00409	CcSEcCtD
Ropivacaine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000274	0.00404	CcSEcCtD
Ropivacaine—Cough—Lisinopril—dilated cardiomyopathy	0.000272	0.00401	CcSEcCtD
Ropivacaine—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000269	0.0035	CbGpPWpGaD
Ropivacaine—Urticaria—Furosemide—dilated cardiomyopathy	0.000269	0.00397	CcSEcCtD
Ropivacaine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000268	0.00395	CcSEcCtD
Ropivacaine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000268	0.00395	CcSEcCtD
Ropivacaine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000266	0.00392	CcSEcCtD
Ropivacaine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000266	0.00392	CcSEcCtD
Ropivacaine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000266	0.00392	CcSEcCtD
Ropivacaine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000265	0.0039	CcSEcCtD
Ropivacaine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000262	0.00387	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000261	0.0034	CbGpPWpGaD
Ropivacaine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000257	0.00378	CcSEcCtD
Ropivacaine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000255	0.00375	CcSEcCtD
Ropivacaine—Infection—Lisinopril—dilated cardiomyopathy	0.000253	0.00373	CcSEcCtD
Ropivacaine—Shock—Lisinopril—dilated cardiomyopathy	0.00025	0.00369	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00025	0.00325	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00025	0.00369	CcSEcCtD
Ropivacaine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000249	0.00367	CcSEcCtD
Ropivacaine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000248	0.00366	CcSEcCtD
Ropivacaine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000247	0.00365	CcSEcCtD
Ropivacaine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000246	0.00363	CcSEcCtD
Ropivacaine—Asthenia—Furosemide—dilated cardiomyopathy	0.000243	0.00359	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00024	0.00312	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00024	0.00312	CbGpPWpGaD
Ropivacaine—Pruritus—Furosemide—dilated cardiomyopathy	0.00024	0.00354	CcSEcCtD
Ropivacaine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000238	0.00351	CcSEcCtD
Ropivacaine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000237	0.00308	CbGpPWpGaD
Ropivacaine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000232	0.00342	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000232	0.00342	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000232	0.00301	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000232	0.00301	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000231	0.003	CbGpPWpGaD
Ropivacaine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00023	0.00339	CcSEcCtD
Ropivacaine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000229	0.00337	CcSEcCtD
Ropivacaine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000227	0.00335	CcSEcCtD
Ropivacaine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000226	0.00334	CcSEcCtD
Ropivacaine—Dizziness—Furosemide—dilated cardiomyopathy	0.000224	0.00331	CcSEcCtD
Ropivacaine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000224	0.0033	CcSEcCtD
Ropivacaine—Pain—Lisinopril—dilated cardiomyopathy	0.000218	0.00321	CcSEcCtD
Ropivacaine—Constipation—Lisinopril—dilated cardiomyopathy	0.000218	0.00321	CcSEcCtD
Ropivacaine—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000217	0.00282	CbGpPWpGaD
Ropivacaine—Vomiting—Furosemide—dilated cardiomyopathy	0.000216	0.00318	CcSEcCtD
Ropivacaine—Rash—Furosemide—dilated cardiomyopathy	0.000214	0.00315	CcSEcCtD
Ropivacaine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000214	0.00315	CcSEcCtD
Ropivacaine—Headache—Furosemide—dilated cardiomyopathy	0.000213	0.00313	CcSEcCtD
Ropivacaine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00021	0.00309	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000208	0.00307	CcSEcCtD
Ropivacaine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000202	0.00298	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000202	0.00263	CbGpPWpGaD
Ropivacaine—Nausea—Furosemide—dilated cardiomyopathy	0.000201	0.00297	CcSEcCtD
Ropivacaine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000201	0.00297	CcSEcCtD
Ropivacaine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000201	0.00297	CcSEcCtD
Ropivacaine—SCN8A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000196	0.00254	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000193	0.00251	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000188	0.00277	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000186	0.00243	CbGpPWpGaD
Ropivacaine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000183	0.00269	CcSEcCtD
Ropivacaine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00018	0.00266	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000178	0.00232	CbGpPWpGaD
Ropivacaine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000174	0.00257	CcSEcCtD
Ropivacaine—SCN2A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000171	0.00223	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000171	0.00223	CbGpPWpGaD
Ropivacaine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000168	0.00248	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000167	0.00217	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000165	0.00215	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000165	0.00215	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000163	0.00213	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000163	0.00212	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—RAC1—dilated cardiomyopathy	0.000162	0.00211	CbGpPWpGaD
Ropivacaine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000162	0.00239	CcSEcCtD
Ropivacaine—Rash—Lisinopril—dilated cardiomyopathy	0.00016	0.00237	CcSEcCtD
Ropivacaine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00016	0.00236	CcSEcCtD
Ropivacaine—Headache—Lisinopril—dilated cardiomyopathy	0.000159	0.00235	CcSEcCtD
Ropivacaine—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000158	0.00206	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000156	0.00203	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000151	0.00197	CbGpPWpGaD
Ropivacaine—Nausea—Lisinopril—dilated cardiomyopathy	0.000151	0.00223	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00015	0.00195	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00015	0.00195	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000145	0.00189	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000145	0.00189	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000145	0.00188	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000145	0.00188	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000144	0.00188	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00014	0.00182	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00014	0.00182	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	0.000131	0.00171	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—RAC1—dilated cardiomyopathy	0.000126	0.00163	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CD36—dilated cardiomyopathy	0.000123	0.0016	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—RAC1—dilated cardiomyopathy	0.000121	0.00157	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	0.000121	0.00157	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000117	0.00152	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000116	0.00151	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—RAC1—dilated cardiomyopathy	0.000116	0.00151	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000116	0.00151	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000116	0.00151	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000112	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000109	0.00142	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—RAF1—dilated cardiomyopathy	0.000108	0.0014	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000107	0.00139	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000107	0.00139	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000105	0.00136	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000103	0.00134	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000103	0.00134	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000102	0.00132	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	9.95e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	9.85e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	9.52e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	9.38e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	9.14e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	9.14e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	8.97e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	8.82e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	8.82e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	8.71e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	8.62e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	8.62e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	8.33e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	8.31e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	8.31e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	8.19e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	8.01e-05	0.00104	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	8.01e-05	0.00104	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	7.72e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	7.72e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—RAF1—dilated cardiomyopathy	7.69e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—EGFR—dilated cardiomyopathy	7.39e-05	0.000961	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	7.27e-05	0.000945	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	6.83e-05	0.000888	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.49e-05	0.000844	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.36e-05	0.000827	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	6.22e-05	0.000809	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	6.2e-05	0.000806	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.1e-05	0.000794	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	5.98e-05	0.000777	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	5.95e-05	0.000774	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	5.84e-05	0.00076	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	5.72e-05	0.000743	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	5.71e-05	0.000743	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	5.71e-05	0.000743	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	5.51e-05	0.000717	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	5.51e-05	0.000717	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	5.49e-05	0.000714	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	5.49e-05	0.000714	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	5.43e-05	0.000706	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	5.29e-05	0.000689	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	5.29e-05	0.000689	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—dilated cardiomyopathy	5.27e-05	0.000686	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—dilated cardiomyopathy	5.02e-05	0.000653	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	4.91e-05	0.000639	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	4.68e-05	0.000609	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4.68e-05	0.000609	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	4.62e-05	0.000601	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.46e-05	0.00058	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	4.46e-05	0.00058	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	4.26e-05	0.000555	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	4.18e-05	0.000543	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	4.08e-05	0.00053	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	4.06e-05	0.000528	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	3.92e-05	0.00051	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	3.92e-05	0.00051	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	3.88e-05	0.000505	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	3.87e-05	0.000504	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	3.78e-05	0.000491	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	3.78e-05	0.000491	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	3.73e-05	0.000485	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	3.73e-05	0.000485	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	3.72e-05	0.000484	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	3.6e-05	0.000468	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	3.6e-05	0.000468	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.41e-05	0.000444	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.21e-05	0.000417	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.9e-05	0.000377	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.89e-05	0.000376	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	2.72e-05	0.000354	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	2.66e-05	0.000345	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	2.53e-05	0.000329	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	2.46e-05	0.00032	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.23e-05	0.00029	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.1e-05	0.000273	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.9e-05	0.000247	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.5e-05	0.000195	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.46e-05	0.00019	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.32e-05	0.000171	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.13e-05	0.000148	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.1e-05	0.000144	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	9.95e-06	0.000129	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	7.88e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	7.68e-06	9.99e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.91e-06	8.99e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	6.68e-06	8.69e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	6.5e-06	8.46e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.86e-06	7.62e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.15e-06	6.7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.02e-06	6.53e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.52e-06	5.88e-05	CbGpPWpGaD
